Arvee Laboratories (India) Ltd (ARVEE) share price, results, shareholding

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Standalone, Rs crore

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	8.91	7.70	6.14	10.60	12.53	8.91	6.45	7.48	3.45	9.78	10.80	17.23
Expenses	8.22	7.17	5.35	9.06	11.03	8.57	6.23	7.14	3.33	8.15	9.70	14.74
Operating Profit	0.69	0.53	0.79	1.54	1.50	0.34	0.22	0.34	0.12	1.63	1.10	2.49
OPM %	7.74%	6.88%	12.87%	14.53%	11.97%	3.82%	3.41%	4.55%	3.48%	16.67%	10.19%	14.45%
Other Income	0.09	0.19	0.21	0.11	0.16	0.19	0.21	0.17	0.23	0.14	0.15	0.18
Interest	0.08	0.05	0.05	0.08	0.05	0.05	0.07	0.04	0.04	0.07	0.08	0.06
Depreciation	0.42	0.35	0.37	0.31	0.30	0.28	0.27	0.29	0.30	0.30	0.31	0.32
Profit before tax	0.28	0.32	0.58	1.26	1.31	0.20	0.09	0.18	0.01	1.40	0.86	2.29
Tax %	25.00%	25.00%	81.03%	25.40%	25.19%	25.00%	22.22%	5.56%	0.00%	-30.71%	38.37%	26.20%
Net Profit	0.21	0.24	0.12	0.94	0.98	0.15	0.07	0.17	0.01	1.83	0.52	1.69
EPS in Rs	0.19	0.22	0.11	0.85	0.89	0.14	0.06	0.15	0.01	1.66	0.47	1.53

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	26.82	34.44	47.78	54.90	45.42	47.38	40.33	61.35	30.35	38.49	31.51	41.26
Expenses	21.83	28.54	40.61	48.73	39.40	41.31	34.65	54.06	27.41	34.88	28.33	35.92
Operating Profit	4.99	5.90	7.17	6.17	6.02	6.07	5.68	7.29	2.94	3.61	3.18	5.34
OPM %	18.61%	17.13%	15.01%	11.24%	13.25%	12.81%	14.08%	11.88%	9.69%	9.38%	10.09%	12.94%
Other Income	0.10	0.51	0.23	0.35	0.35	0.56	0.46	1.35	0.64	0.66	0.69	0.70
Interest	3.07	3.48	3.33	1.63	0.99	0.58	0.37	0.39	0.25	0.25	0.23	0.25
Depreciation	1.49	2.07	2.15	2.35	2.29	2.41	2.32	2.08	1.50	1.15	1.21	1.23
Profit before tax	0.53	0.86	1.92	2.54	3.09	3.64	3.45	6.17	1.83	2.87	2.43	4.56
Tax %	66.04%	-81.40%	43.23%	11.02%	25.89%	26.37%	25.51%	33.23%	42.62%	25.09%	-3.70%
Net Profit	0.19	1.55	1.09	2.26	2.30	2.68	2.57	4.12	1.05	2.15	2.53	4.05
EPS in Rs	0.23	1.91	0.99	2.05	2.09	2.43	2.33	3.74	0.95	1.95	2.30	3.67
Dividend Payout %	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

	10 Years	5 Years	3 Years	TTM	1 Year	Last Year
Compounded Sales Growth	2%	-8%	-20%	17%
Compounded Profit Growth	29%	-1%	-17%	196%
Stock Price CAGR	%	21%	27%		43%
Return on Equity	10%	9%	6%			7%

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4.05	4.05	5.51	5.51	5.51	11.02	11.02	11.02	11.02	11.02	11.02
Reserves	-1.41	0.15	8.69	10.95	13.25	10.42	12.92	17.04	18.09	20.24	22.77
Borrowings	25.32	24.99	16.15	12.87	3.87	8.88	3.13	1.00	1.00	1.03	1.11
Other Liabilities	7.25	6.49	13.77	7.81	11.00	10.73	11.61	9.63	8.45	5.29	7.99
Total Liabilities	35.21	35.68	44.12	37.14	33.63	41.05	38.68	38.69	38.56	37.58	42.89
Fixed Assets	13.15	16.88	14.88	12.65	13.18	13.81	13.84	12.68	12.67	15.27	16.72
CWIP	4.30	0.00	1.18	2.32	1.78	0.97	0.98	1.53	2.62	0.73	0.90
Investments	0.00	0.00	0.00	1.95	3.09	2.03	0.00	0.00	0.00	0.00	1.70
Other Assets	17.76	18.80	28.06	20.22	15.58	24.24	23.86	24.48	23.27	21.58	23.57
Total Assets	35.21	35.68	44.12	37.14	33.63	41.05	38.68	38.69	38.56	37.58	42.89

	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from Operating Activity	4.03	6.02	9.46	10.31	1.71	0.68	2.93	3.66	-0.21	-0.12
Cash from Investing Activity	-1.40	-1.23	-2.85	-3.08	-0.60	0.06	-1.26	-2.16	-1.32	0.50
Cash from Financing Activity	-2.92	-3.78	-4.92	-9.90	4.52	-6.06	-2.42	-0.19	-0.12	-0.16
Net Cash Flow	-0.29	1.00	1.68	-2.67	5.63	-5.32	-0.75	1.31	-1.64	0.23
Free Cash Flow	2.54	4.68	7.96	8.02	-0.53	-1.68	1.47	1.07	-2.06	-2.95
CFO/OP	57%	96%	158%	184%	44%	29%	64%	139%	10%	3%

	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor Days	82.61	87.12	118.25	52.66	52.40	60.70	109.78	72.94	73.48	79.66	121.05
Inventory Days	155.08	104.53	99.61	42.90	80.96	91.96	93.24	42.29	159.02	80.31	228.81
Days Payable	130.73	98.14	150.03	55.84	125.63	118.08	160.12	73.30	164.49	57.72	159.35
Cash Conversion Cycle	106.96	93.50	67.84	39.72	7.72	34.59	42.90	41.94	68.01	102.25	190.51
Working Capital Days	30.08	30.84	30.79	-6.52	10.29	-10.63	49.96	70.44	95.97	103.55	168.43
ROCE %		15.19%	17.64%	13.67%	14.90%	14.92%	12.89%	23.34%	6.83%	9.58%	7.53%

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoters	73.50%	73.50%	73.50%	73.50%	73.50%	73.50%	73.50%	73.50%	73.50%	73.50%	73.50%	73.50%
Public	26.50%	26.50%	26.50%	26.50%	26.50%	26.50%	26.50%	26.50%	26.50%	26.50%	26.50%	26.50%
No. of Shareholders	905	1,372	1,298	1,480	1,416	1,623	1,576	1,505	1,505	1,861	1,638	1,596

Fundamentals

Market Cap₹ 257 Cr.

Current Price₹ 233

Stock P/E63.4

Book Value₹ 30.7

ROCE7.53 %

ROE7.32 %

Dividend Yield0.00 %

Face Value₹ 10.0

Compounded Sales Growth (TTM)17%

Compounded Profit Growth (TTM)196%

Standalone figures.

Valuation

Market capRs 237 Cr

Enterprise valueRs 237 Cr

P/E (TTM)58.59x

Price to book7.02x

Price to sales5.75x

EV / EBITDA39.21x

EV / EBIT49.24x

EV / sales5.74x

Earnings yield1.71%

P/E, 3-year average93.86x

P/B, 3-year average4.93x

P/E, 5-year average70.78x

P/B, 5-year average4.70x

Profitability

Operating margin (excl. other income)10.09%

Operating margin (incl. other income)12.28%

EBITDA margin14.64%

Pre-tax margin11.05%

Net profit margin9.82%

Net margin, latest quarter9.81%

ROE7.78%

ROCE7.92%

ROA6.29%

ROE, 3-year average6.19%

ROCE, 3-year average8.32%

ROA, 3-year average4.88%

ROE, 5-year average9.15%

ROCE, 5-year average12.33%

ROA, 5-year average6.35%

ROIC (approx.)14.97%

Tax rate-3.70%

Other income / net worth2.04%

Growth

Sales growth (latest year)-18.13%

Profit growth (latest year)17.67%

Sales CAGR, 3 years-19.92%

Sales CAGR, 5 years-7.83%

Profit CAGR, 3 years-15.00%

Profit CAGR, 5 years-1.15%

Sales growth QoQ59.54%

Profit growth QoQ225.00%

Sales growth YoY (latest quarter)130.35%

Profit growth YoY (latest quarter)894.12%

Per share

EPS (TTM)Rs 3.68

EPS (latest year)Rs 2.30

EPS (latest quarter)Rs 1.53

EPS, 3-year averageRs 1.73

EPS, 5-year averageRs 2.25

Book value per shareRs 30.66

Sales per shareRs 37.44

Cash flow per shareRs -0.11

Free cash flow per shareRs -2.68

Efficiency

Asset turnover0.73x

Fixed asset turnover1.88x

Inventory turnover2.04x

Inventory days179 days

Debtor days121 days

Debtors turnover3.02x

Creditor days159 days

Cash conversion cycle191 days

Working capital days168 days

Leverage

Total debtRs 1 Cr

Cash and bankRs 2 Cr

Net debtRs -0 Cr

Debt to equity0.03x

Net debt / EBITDA-0.08x

Interest coverage19.24x

Owners' fund to total sources78.78%

Debt to assets2.59%

Cash flow

Cash from Operating Activity (latest year)Rs -0 Cr

Cash from Investing Activity (latest year)Rs 0 Cr

Cash from Financing Activity (latest year)Rs -0 Cr

Net Cash Flow (latest year)Rs 0 Cr

Free cash flow (latest year)Rs -3 Cr

FCFE (approx.: FCF + change in debt)Rs -3 Cr

Cash from ops / profit, 5 years0.56x

Statement figures

Net sales (TTM)Rs 41 Cr

Net sales (latest year)Rs 32 Cr

Sales (latest quarter)Rs 17 Cr

Operating profit excl. other income (latest year)Rs 3 Cr

Operating profit (latest quarter)Rs 2 Cr

Other income (TTM)Rs 1 Cr

EBITDA (TTM)Rs 6 Cr

PBDT (TTM)Rs 6 Cr

Profit before tax (TTM)Rs 5 Cr

Tax (latest year)Rs -0 Cr

Net profit (TTM)Rs 4 Cr

Net profit (latest year)Rs 3 Cr

Net profit (latest quarter)Rs 2 Cr

Depreciation (TTM)Rs 1 Cr

Depreciation (latest quarter)Rs 0 Cr

Interest (TTM)Rs 0 Cr

Cost of goods sold (latest year)Rs 19 Cr

Total expenditure (latest year)Rs 28 Cr

Total income (latest year)Rs 32 Cr

Share capitalRs 11 Cr

ReservesRs 23 Cr

Shareholders' fundsRs 34 Cr

Total assetsRs 43 Cr

Net blockRs 17 Cr

Capital work in progressRs 1 Cr

InvestmentsRs 2 Cr

ReceivablesRs 10 Cr

InventoryRs 9 Cr

Other liabilitiesRs 8 Cr

Shares outstanding (crore)1.10

Ownership

Promoter holding73.50% (+0.00 in a year)

Computed by MarketFriction from the standalone statements. Returns use average balances.

P/E 58.6 is at the 65th percentile of its own 7.2-year range (median 46.3, low 19.1, high 201.7).

P/B 7.02 is at the 87th percentile (median 5.36).

Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.

Period	ARVEE	Nifty 50	Difference
1 week	-4.0%	-2.8%	-1.2 pts
1 month	+31.1%	-6.8%	+37.9 pts
3 months	+30.5%	-7.6%	+38.1 pts
6 months	+60.4%	+0.4%	+60.0 pts
1 year	+19.3%	-9.9%	+29.2 pts
2 years	+19.6%	-13.6%	+33.2 pts
3 years	+89.1%	+14.2%	+75.0 pts
5 years	+142.6%	+27.9%	+114.7 pts

Red flags

F-score 5 of 8

explain	Receivables outrunning sales Receivables grew 24% vs sales -18% in 2026
look	Inventory outrunning sales Inventory grew 102% vs sales -18% in 2026
look	On NSE surveillance On NSE surveillance: ASM long-term

Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026

Sales ₹17 Cr +130.3% vs Jun 2025. Net profit ₹2 Cr +894.1%.

Activity

Compare

Company	Mcap (Cr)	P/E	ROCE
Pidilite Industries Ltd	148,809	56.2	31.0 %
Gujarat Fluorochemicals Ltd	48,402	78.4	9.64 %
Navin Fluorine International Ltd	42,255	53.1	21.0 %
Aether Industries Ltd	23,226	96.8	11.9 %
Deepak Nitrite Ltd	20,854	26.3	11.4 %
Atul Ltd	17,614	22.1	14.9 %
Aarti Industries Ltd	17,045	32.6	6.86 %
Fine Organic Industries Ltd	15,759	36.0	21.5 %
BASF India Ltd	14,871	24.0	14.5 %
Privi Speciality Chemicals Ltd	14,084	40.3	22.3 %
Anupam Rasayan India Ltd	13,409	76.8	7.38 %
Vinati Organics Ltd	12,173	24.4	21.4 %
Elantas Beck India Ltd	10,820	60.9	21.2 %
Jubilant Ingrevia Ltd	10,180	32.0	11.4 %
Alkyl Amines Chemicals Ltd	9,111	40.5	16.6 %

No bulk or block deals on record.

Ex-date	Action	Factor
2024-09-20	Annual General Meeting
2023-09-15	Annual General Meeting
2022-07-28	Annual General Meeting
2021-09-16	Annual General Meeting

Date	Type	What it says
2026-09-30	Shareholder meeting	Voting results.
2026-09-29	Shareholder meeting	Proceedings of Annual General Meeting held today that is 29th September, 2026
2026-09-09	Cessation	Cessation of Mrs Raina Singh as Company Secretary & Compliance Officer of the company w.e.f. September 09, 2026.
2026-08-07	Board meeting outcome	Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended Jun 30, 2026.
2026-08-04	Corrigendum	Corrigendum to Other
2026-06-15	Disclosure under SEBI Takeov	Shalin Patel has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acqu...
2026-05-19	Board meeting outcome	Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
2026-04-15	Price movement	Significant movement in price has been observed in Arvee Laboratories (India) Limited. The Exchange, in order to ensure that investors have latest rel...
2026-04-13	Price movement	Significant movement in price has been observed in Arvee Laboratories (India) Limited. The Exchange, in order to ensure that investors have latest rel...
2026-03-06	Price movement	Significant movement in price has been observed in Arvee Laboratories (India) Limited. The Exchange, in order to ensure that investors have latest rel...
2026-02-13	Board meeting outcome	Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
2026-02-13	Board meeting outcome	Board meeting held on February 13, 2026.
2026-02-09	Corrigendum	Corrigendum to Board Meeting to be held on 13th february 2026
2025-12-24	Price movement	Significant movement in price has been observed in Arvee Laboratories (India) Limited. The Exchange, in order to ensure that investors have latest rel...
2025-12-19	Price movement	Significant movement in price has been observed in Arvee Laboratories (India) Limited. The Exchange, in order to ensure that investors have latest rel...
2025-11-14	Board meeting outcome	Arvee Laboratories (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.

Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.

No short selling reported to NSE in our files.

Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.

Long Term Additional Surveillance Measure (Long Term ASM): stage 1Scrip PE is greater than 50 (4 trailing quarters)